Bone Regeneration Market is expected to reach US$ 7.4 Billion by 2032, at a CAGR of 3.8%

The global Bone Regeneration Market size is expected to be worth US$ 5.1 billion in 2022 and to grow at a CAGR of 3.8% to reach US$ 7.4 billion by 2032. In terms of product type, bone graft substitutes dominated the market in 2021, accounting for 81.4% of the total.

Bone Regeneration refers to a well-organized and complex physiological process of bone growth. Certain bone problems are caused by bone insufficiency. Bone remodelling is required by the intricate process of Bone Regeneration. Musculoskeletal disorders are becoming more common worldwide. The prevalence of common musculoskeletal disorders such as osteoarthritis, osteoporosis, and joint inflammation is rising, resulting in market growth.

Request a Report Sample and Gain a Competitive Advantage@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15486

Furthermore, as per-care costs continue to rise year after year, increasing global health spending, treatment for these conditions adds to the overall cost of pharmaceutical charges. The enhanced reimbursement scenario includes orthopaedic treatment. Medicare, for example, spent $799.4 billion in 2019 on benefit payments for approximately 61 million people aged 65 and older or disabled.

In the same year, Medicaid spent US$ 138.7 billion on acute care services such as hospitalisation, doctor visits, and prescribed medications. When there is a better reimbursement scenario, more patients will choose the treatment. The market for Bone Regeneration is expected to grow in the future because this factor is positive. The development of novel, advanced technologies is expected to drive up demand for Bone Regeneration during the forecast period.

Key Takeaways from Bone Regeneration Study

• Bone graft substitute products are expected to account for approximately 83.4% of the market value by the end of 2032, with a CAGR of 4.1% over the forecast period.
• Trauma cases have a dominant market share value of 22.6% in the global market in 2021. Because trauma is the leading cause of death, there will be positive growth during the forecast period.
• In the global market, the adult segment has a dominant market share of 56.8% in 2021.
• In terms of market share value, hospitals have a higher end-user segment share of 49.1% in 2021. Because most surgeries are critical and time-consuming, they require a proper operating environment. Most surgeries are performed in hospitals to ensure patient safety.
• At the end of the forecast period, North America is expected to be the largest leading region, with a market value of 39.0%. Because of the region’s high prevalence of joint diseases.

“Increasing prevalence of orthopedic diseases, rising incidence of bone fractures is expected to drive demand for Bone Regeneration market during the next decade,” says the FMI Analyst

Last few days to get reports at discounted prices, offer expires soon!

Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-15486

Market Competition

The market for Bone Regeneration is moderately fragmented, and there exist, several local, emerging, as well as established players within the market sphere. Key players have initiated promotional activities to introduce new products with continued collaboration and expansion activities

• In November 2021, Johnson & Johnson received 510(k) FDA clearance for the VELYSTM Robotic-Assisted Solution for use with the ATTUNE® Total Knee System, allowing surgeons to streamline their current workflows on a typical orthopaedic procedure.
• Altapore Shape bioactive bone graft, the newest addition to Baxter’s line of next-generation bone graft substitutes, received FDA approval in September 2020.

Key Players:

• Medtronic plc.
• Stryker Corporation
• DePuy Synthes, Inc.
• Integra Lifesciences Holdings Corporation
• Zimmer Biomet Holdings, Inc.
• Xtant Medical Holdings, Inc.
• Arthrex, Inc.
• Baxter International Inc.
• Others

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-15486

Key Market Segments Covered in Bone Regeneration Industry Research

By Product:

• Bone Grafts Substitutes
  • Allografts
    • Demineralized Bone Matrix(DBM)
    • Others
  • Xenograft
  • Autografts
  • Synthetic Bone Graft
  • Bone Morphogenetic Protein(BMP)
• Bone Growth Stimulators
  • Non-Invasive Electrical Bone Growth Stimulators
  • Invasive Electrical Bone Growth Stimulators

By Application:

• Osteoarthritis (OA)
• Osteoporosis
• Rheumatoid Arthritis (RA)
• Spinal Disorders
• Dentistry
• Craniomaxillofacial (CMF)
• Trauma Cases

By Age Group:

• Pediatric
• Adults
• Geriatric

By End User:

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs